|
1
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 (Suppl 7):vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arndt CA, Rose PS, Folpe AL and Laack NN:
Common musculoskeletal tumors of childhood and adolescence. Mayo
Clin Proc. 87:475–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gianferante DM, Mirabello L and Savage SA:
Germline and somatic genetics of osteosarcoma-connecting aetiology,
biology and therapy. Nat Rev Endocrinol. 13:480–491. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrari S and Serra M: An update on
chemotherapy for osteosarcoma. Expert Opin Pharmacother.
16:2727–2736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee C and Kikyo N: Strategies to identify
long noncoding RNAs involved in gene regulation. Cell Biosci.
2:372012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Li J, Liang D, Zhang L and Wang Q:
LncRNA AWPPH participates in the development of non-traumatic
osteonecrosis of femoral head by upregulating Runx2. Exp Ther Med.
19:153–159. 2020.PubMed/NCBI
|
|
7
|
Wang Y, Mei C, Su X, Wang H, Yang W and
Zan L: MEF2A regulates the MEG3-DIO3 miRNA mega cluster-targeted
PP2A signaling in bovine skeletal myoblast differentiation. Int J
Mol Sci. 20:27482019. View Article : Google Scholar
|
|
8
|
Nolte W, Weikard R, Brunner RM, Albrecht
E, Hammon HM, Reverter A and Kühn C: Biological network approach
for the identification of regulatory long non-coding RNAs
associated with metabolic efficiency in cattle. Front Genet.
10:11302019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guan H, Mei Y, Mi Y, Li C, Sun X, Zhao X,
Liu J, Cao W, Li Y and Wang Y: Downregulation of lncRNA ANRIL
suppresses growth and metastasis in human osteosarcoma cells.
OncoTargets Ther. 11:4893–4899. 2018. View Article : Google Scholar
|
|
10
|
Liu D, Zhang H, Cong J, Cui M, Ma M, Zhang
F, Sun H and Chen C: H3K27 acetylation-induced lncRNA EIF3J-AS1
improved proliferation and impeded apoptosis of colorectal cancer
through miR-3163/YAP1 axis. J Cell Biochem. 121:1923–1933. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Huang Z, Qian W, Zhang Q and Sun J:
Silence of lncRNA UCA1 rescues drug resistance of cisplatin to
non-small-cell lung cancer cells. J Cell Biochem. 120:9243–9249.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han N, Zuo L, Chen H, Zhang C, He P and
Yan H: Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS)
promotes retinoblastoma progression via sponging miR-506-3p.
OncoTargets Ther. 12:3509–3517. 2019. View Article : Google Scholar
|
|
13
|
Guo F, Fu Q, Wang Y and Sui G: Long
non-coding RNA NR2F1-AS1 promoted proliferation and migration yet
suppressed apoptosis of thyroid cancer cells through regulating
miRNA-338-3p/CCND1 axis. J Cell Mol Med. 23:5907–5919. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang C, Liu Z, Chang X, Xu W, Gong J, Chai
F and Cui D: NR2F1-AS1 regulated miR-423-5p/SOX12 to promote
proliferation and invasion of papillary thyroid carcinoma. J Cell
Biochem. 121:2009–2018. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Zhao S and Mingxin YU: LncRNA
NR2F1-AS1 is involved in the progression of endometrial cancer by
sponging miR-363 to target SOX4. Pharmazie. 74:295–300.
2019.PubMed/NCBI
|
|
16
|
Li S, Zheng K, Pei Y, Wang W and Zhang X:
Long noncoding RNA NR2F1-AS1 enhances the malignant properties of
osteosarcoma by increasing forkhead box A1 expression via sponging
of microRNA-483-3p. Aging (Albany NY). 11:11609–11623. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gulino R, Forte S, Parenti R, Memeo L and
Gulisano M: MicroRNA and pediatric tumors: Future perspectives.
Acta Histochem. 117:339–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng YC, Lin T, Jiang H, Zhang Z, Shu L,
Yin J, Ma X, Wang C, Gao R and Zhou XH: MiR-122 Exerts inhibitory
effects on osteoblast proliferation/differentiation in osteoporosis
by activating the PCP4-mediated JNK pathway. Mol Ther Nucleic
Acids. 20:345–358. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan YX, Hong Y, Jiang S, Lu MN, Li S, Chen
B, Zhang L, Hu T, Mao R, Mei R and Xiyang YB: MicroRNA-449a
regulates the progression of brain aging by targeting SCN2B in
SAMP8 mice. Int J Mol Med. 45:1091–1102. 2020.PubMed/NCBI
|
|
20
|
Fan H, Lu S, Wang S and Zhang S:
Identification of critical genes associated with human osteosarcoma
metastasis based on integrated gene expression profiling. Mol Med
Rep. 20:915–930. 2019.PubMed/NCBI
|
|
21
|
Xuan C, Jin M, Gao Y, Xu S, Wang L, Wang
Y, Han R and An Q: MiR-218 suppresses the proliferation of
osteosarcoma through downregulation of E2F2. Oncol Lett.
17:571–577. 2019.PubMed/NCBI
|
|
22
|
Wang DZ, Jing SF, Hao SB, Huang XY, Miao
QT and Gao JF: MiR-218 promotes apoptosis of U2OS osteosarcoma
cells through targeting BIRC5. Eur Rev Med Pharmacol Sci.
22:6650–6657. 2018.PubMed/NCBI
|
|
23
|
Jin J, Cai L, Liu ZM and Zhou XS:
MiRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang M, Cai WR, Meng R, Chi JR, Li YR,
Chen AX, Yu Y and Cao XC: MiR-485-5p suppresses breast cancer
progression and chemosensitivity by targeting survivin. Biochem
Biophys Res Commun. 501:48–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yun S, Kim WK, Kwon Y, Jang M, Bauer S and
Kim H: Survivin is a novel transcription regulator of KIT and is
downregulated by miRNA-494 in gastrointestinal stromal tumors. Int
J Cancer. 142:2080–2093. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang XP, Yao J, Guan J, Zhou ZQ, Zhang ZY
and Yang J: MicroRNA-542-3p functions as a tumor suppressor via
directly targeting survivin in hepatocellular carcinoma. Biomed
Pharmacother. 99:817–824. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu X, Zhang Y, Cavazos D, Ma X, Zhao Z, Du
L and Pertsemlidis A: MiR-195 targets cyclin D3 and survivin to
modulate the tumorigenesis of non-small cell lung cancer. Cell
Death Dis. 9:1932018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu DC, Song LL, Liang Q, Hao L, Zhang ZG
and Han CH: Long noncoding RNA LEF1-AS1 silencing suppresses the
initiation and development of prostate cancer by acting as a
molecular sponge of miR-330-5p via LEF1 repression. J Cell Physiol.
234:12727–12744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Emmrich S, Streltsov A, Schmidt F,
Thangapandi VR, Reinhardt D and Klusmann JH: LincRNAs MONC and
MIR100HG act as oncogenes in acute megakaryoblastic leukemia. Mol
Cancer. 13:1712014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suwal A, Hao JL, Liu XF, Zhou DD, Pant OP,
Gao Y, Hui P, Dai XX and Lu CW: NONRATT021972 long-noncoding RNA: A
promising lncRNA in diabetes-related diseases. Int J Med Sci.
16:902–908. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Li R, Ding X, Zhang K and Qin W:
Upregulation of long non-coding RNA SNHG6 promote esophageal
squamous cell carcinoma cell malignancy and its diagnostic value.
Am J Transl Res. 11:1084–1091. 2019.PubMed/NCBI
|
|
34
|
Guan H, Shang G, Cui Y, Liu J, Sun X, Cao
W, Wang Y and Li Y: Long noncoding RNA APTR contributes to
osteosarcoma progression through repression of miR-132-3p and
upregulation of yes-associated protein 1. J Cell Physiol.
234:8998–9007. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng X, Wei F and Hu X: Long noncoding RNA
DLGAP1-AS1 promotes cell proliferation in hepatocellular carcinoma
via sequestering miR-486-5p. J Cell Biochem. 121:1953–1962. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang H, Chen J, Ding CM, Jin X, Jia ZM
and Peng J: LncRNA NR2F1-AS1 regulates hepatocellular carcinoma
oxaliplatin resistance by targeting ABCC1 via miR-363. J Cell Mol
Med. 22:3238–3245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao F, Wu H, Wang R, Guo Y, Zhang Z, Wang
T, Zhang G, Liu C and Liu J: MicroRNA-485-5p suppresses the
proliferation, migration and invasion of small cell lung cancer
cells by targeting flotillin-2. Bioengineered. 10:1–12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H,
Liu W, Bao H, Tu Y and Xie P: MicroRNA-485-5p attenuates cell
proliferation in glioma by directly targeting paired box 3. Am J
Cancer Res. 8:2507–2517. 2018.PubMed/NCBI
|
|
39
|
Zhang JX, Chen ZH, Chen DL, Tian XP, Wang
CY, Zhou ZW, Gao Y, Xu Y, Chen C, Zheng ZS, et al:
LINC01410-miR-532-NCF2-NF-κB feedback loop promotes gastric cancer
angiogenesis and metastasis. Oncogene. 37:2660–2675. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu XX, Xu XN, He BS, Sun HL, Xu T, Liu XX,
Chen XX, Zeng KX, Wang SK and Pan YQ: MicroRNA-485-5p functions as
a tumor suppressor in colorectal cancer cells by targeting CD147. J
Cancer. 9:2603–2611. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang FR, Xu SH, Wang BM and Wang F:
MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by
targeting CX3CL1. Eur Rev Med Pharmacol Sci. 22:7197–7204.
2018.PubMed/NCBI
|
|
42
|
Han DL, Wang LL, Zhang GF, Yang WF, Chai
J, Lin HM, Fu Z and Yu JM: MiRNA-485-5p, inhibits esophageal cancer
cells proliferation and invasion by down-regulating O-linked
N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci.
23:2809–2816. 2019.PubMed/NCBI
|
|
43
|
Xu Y, He Q, Lu Y, Tao F, Zhao L and Ou R:
MicroRNA-218-5p inhibits cell growth and metastasis in cervical
cancer via LYN/NF-κB signaling pathway. Cancer Cell Int.
18:1982018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li X, He J, Shao M, Cui B, Peng F, Li J,
Ran Y, Jin D, Kong J, Chang J, et al: Downregulation of miR-218-5p
promotes invasion of oral squamous cell carcinoma cells via
activation of CD44-ROCK signaling. Biomed Pharmacother.
106:646–654. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu K, Ding H, Wang W, Liao Z, Fu Z, Hong
Y, Zhou Y, Zhang CY and Chen X: Tumor-suppressive miR-218-5p
inhibits cancer cell proliferation and migration via EGFR in
non-small cell lung cancer. Oncotarget. 7:28075–28085. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li G and Kong Q: LncRNA LINC00460 promotes
the papillary thyroid cancer progression by regulating the
LINC00460/miR-485-5p/Raf1 axis. Biol Res. 52:612019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bao W, Cao F, Ni S, Yang J, Li H, Su Z and
Zhao B: lncRNA FLVCR1-AS1 regulates cell proliferation, migration
and invasion by sponging miR-485-5p in human cholangiocarcinoma.
Oncol Lett. 18:2240–2247. 2019.PubMed/NCBI
|
|
48
|
Wang J, Shu HZ, Xu CY and Guo SG: LncRNA
DGCR5 promotes non-small cell lung cancer progression via sponging
miR-218-5p. Eur Rev Med Pharmacol Sci. 23:9947–9954.
2019.PubMed/NCBI
|
|
49
|
Zhang G, He X, Ren C, Lin J and Wang Q:
Long noncoding RNA PCA3 regulates prostate cancer through sponging
miR-218-5p and modulating high mobility group box 1. J Cell
Physiol. 234:13097–13109. 2019. View Article : Google Scholar : PubMed/NCBI
|
